_version_ 1785091142530891776
author Veleanu, Layla
Tesson, Bruno
Lamant, Laurence
Marçais, Ambroise
Bruneau, Julie
Kaltenbach, Sophie
Brouzes, Chantal
Degoutte, Charlotte
Moraly, Josquin
Villarese, Patrick
Lhermitte, Ludovic
Latiri, Mehdi
Hure, Gregoire
Chauchet, Adrien
Delette, Caroline
Grosleron, Sylvie
Toussaint, Elise
Cabrera, Quentin
Brice, Pauline
Gros, Francois-Xavier
Clavert, Aline
Oberic, Lucie
Legoff, Marielle
Cereja, Sophie
Meggetto, Fabienne
Macintyre, Elizabeth
Asnafi, Vahid
Sibon, David
author_facet Veleanu, Layla
Tesson, Bruno
Lamant, Laurence
Marçais, Ambroise
Bruneau, Julie
Kaltenbach, Sophie
Brouzes, Chantal
Degoutte, Charlotte
Moraly, Josquin
Villarese, Patrick
Lhermitte, Ludovic
Latiri, Mehdi
Hure, Gregoire
Chauchet, Adrien
Delette, Caroline
Grosleron, Sylvie
Toussaint, Elise
Cabrera, Quentin
Brice, Pauline
Gros, Francois-Xavier
Clavert, Aline
Oberic, Lucie
Legoff, Marielle
Cereja, Sophie
Meggetto, Fabienne
Macintyre, Elizabeth
Asnafi, Vahid
Sibon, David
author_sort Veleanu, Layla
collection PubMed
description
format Online
Article
Text
id pubmed-10431189
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311892023-08-17 P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN Veleanu, Layla Tesson, Bruno Lamant, Laurence Marçais, Ambroise Bruneau, Julie Kaltenbach, Sophie Brouzes, Chantal Degoutte, Charlotte Moraly, Josquin Villarese, Patrick Lhermitte, Ludovic Latiri, Mehdi Hure, Gregoire Chauchet, Adrien Delette, Caroline Grosleron, Sylvie Toussaint, Elise Cabrera, Quentin Brice, Pauline Gros, Francois-Xavier Clavert, Aline Oberic, Lucie Legoff, Marielle Cereja, Sophie Meggetto, Fabienne Macintyre, Elizabeth Asnafi, Vahid Sibon, David Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431189/ http://dx.doi.org/10.1097/01.HS9.0000971560.73604.5e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Veleanu, Layla
Tesson, Bruno
Lamant, Laurence
Marçais, Ambroise
Bruneau, Julie
Kaltenbach, Sophie
Brouzes, Chantal
Degoutte, Charlotte
Moraly, Josquin
Villarese, Patrick
Lhermitte, Ludovic
Latiri, Mehdi
Hure, Gregoire
Chauchet, Adrien
Delette, Caroline
Grosleron, Sylvie
Toussaint, Elise
Cabrera, Quentin
Brice, Pauline
Gros, Francois-Xavier
Clavert, Aline
Oberic, Lucie
Legoff, Marielle
Cereja, Sophie
Meggetto, Fabienne
Macintyre, Elizabeth
Asnafi, Vahid
Sibon, David
P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
title P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
title_full P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
title_fullStr P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
title_full_unstemmed P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
title_short P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
title_sort p1166: brigatinib in patients with alk-positive anaplastic large cell lymphoma who have failed brentuximab vedotin
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431189/
http://dx.doi.org/10.1097/01.HS9.0000971560.73604.5e
work_keys_str_mv AT veleanulayla p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT tessonbruno p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT lamantlaurence p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT marcaisambroise p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT bruneaujulie p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT kaltenbachsophie p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT brouzeschantal p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT degouttecharlotte p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT moralyjosquin p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT villaresepatrick p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT lhermitteludovic p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT latirimehdi p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT huregregoire p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT chauchetadrien p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT delettecaroline p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT grosleronsylvie p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT toussaintelise p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT cabreraquentin p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT bricepauline p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT grosfrancoisxavier p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT clavertaline p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT obericlucie p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT legoffmarielle p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT cerejasophie p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT meggettofabienne p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT macintyreelizabeth p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT asnafivahid p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin
AT sibondavid p1166brigatinibinpatientswithalkpositiveanaplasticlargecelllymphomawhohavefailedbrentuximabvedotin